Patent · US Active

Benzimidazole derivatives as adenosine receptor antagonists

US11453647B2 · kind B2 · utility

0Cited by

7References

10Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Eva-Maria TANZER · Darmstadt, DE
Kai Schiemann · Darmstadt, DE
Markus Klein · Weiterstadt, DE

Key dates

Filing date	Aug 20, 2018
Grant date	Sep 27, 2022
Priority date	—
Expiry date	Aug 20, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.